Create a lasting legacy to fund future research and support programs by donating to The Teal Trust.
Including OCRA in your estate plan is an easy way to commit to funding crucial research for ovarian and related gynecologic cancers now and in the future.
Your lawyer or financial advisor can assist with either creating or adjusting your estate plans.
We recommend that your bequest be designated for unrestricted purposes or be directed to general research because we cannot predict future medical advances or the future of our patient support programs.
FreeWill, a secure online resource that we have partnered with, guides you through the process of making or updating a legally valid will and including a gift to OCRA. The entire process takes less than 20 minutes and is 100% free. This is an easy way to help patients and support survivors well into the future.
FreeWill can also help you easily plan beneficiaries for your non-probate assets (such as an IRA, 401(k), life-insurance policy, or any other assets not included in your will) in one place. You can even designate OCRA as a beneficiary of these kinds of assets if you choose.
Please fill out this form to let us know so we can say thank you and update our records!
Email donations@ocrahope.org or call 212-268-1002 to notify us of your plans or for further information.
SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community. The … Continued
In an article published by Everyday Health, “Coping With the Emotional Challenges of Platinum-Resistant Ovarian Cancer” (June 10, 2026), Ovarian Cancer Research Alliance (OCRA) community member Amanda Widro shares her experience navigating a platinum-resistant ovarian cancer diagnosis. Ovarian cancer is considered platinum-resistant when it recurs within six months of finishing platinum-based chemotherapy. Widro, who was … Continued
Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
